Skip to main content

Table 5 Sex hormones and bone turnover markers of 111 male CD patients divided in subgroups according to Body mass index (BMI)

From: Bones and Crohn's: Estradiol deficiency in men with Crohn's disease is not associated with reduced bone mineral density

 

A

B

C

 
 

BMI < 20 (n = 26)

BMI 20–25 (n = 55)

BMI > 25 (n = 30)

p

 

Median

Range

Median

Range

Median

Range

 

Testosterone (nmol/l)

19.3

8.8 – 34.4

20.4

9.5 – 48

16,95

11.1–37.1

a)

SHBG (nmol/l)

25.6

7.6 – 69.3

22.2

8.5 – 57

17,15

6.9 – 65.1

b)c)

FAI

61.5

19 – 351

90

26 – 338

93

18 – 236

n.s.

DHT (pg/ml)

256

66 – 643

270

84 – 643

275

147 – 750

n.s.

Estradiol (pg/ml)

21.6

14.1 – 41.5

25.5

9.4 – 46.6

27.1

15.3 – 47.8

d)e)

FEI

35

11 – 129

41

9 – 140

57

16 – 143

f)g)h)

Osteocalcin (ng/ml)

3.5

0.7 – 12.1

3.1

0.5 – 12.8

2.7

0.3 – 7.6

n.s.

ICTP (μg/l)

4.9

2.8 – 11.7

3,7

2.1 – 8.3

3.5

1.7 – 5.6

i)j)

lumbar T-score

-2.36

-3.94 – -0.25

-2.06

-3.94–0,4

-1.56

-3.27–0.84

k)l)

Age (yr)

30.5

19 – 47

34

21 – 71

45

26 – 66

m)n)

  1. a) p < 0,05 group B vs. C; b) p < 0,02 group A vs. C; c) p < 0,05 group B vs. C; d) p < 0,05 group A vs. B; e) p = 0,005 group A vs. C;f) p = 0,05 group A vs. B; g) p < 0,001 group A vs. C; h) p < 0,01 group B vs. C;i) p < 0,01 group A vs. B; j) p < 0,001 group A vs. C; k) p < 0,025 group A vs. C;l) p < 0,05 group B vs. C.m) p < 0,001 group A vs. C.n) p < 0,01 group B vs. C.